ErgomedCompany research
Click on headlines below to download research
Adj EBITDA upgrade despite industry challenges
Ergomed | 22/09/2020
H120 adjusted EBITDA of £9.1m was the main positive surprise for us in Ergomed’s full interim report released today. We have increased our adjusted…
Executive interview
Ergomed - executive interview | 12/08/2020
In this interview, Ergomed's CFO Richard Barfield runs through: - The highlights of Ergomed’s recent trading update, with total H120 revenues increasing…
Diversified services offering proves resilient
Ergomed | 23/07/2020
According to Ergomed’s H120 trading update, the business successfully navigated the COVID-19 pandemic in H120. Underlying revenues in the PrimeVigilance…
AGM update: ‘Revenue growth trend’ maintained
Ergomed | 10/06/2020
Today Ergomed held its annual general meeting (AGM). As expected, no new financial details were provided, although the executive chairman released a statement…